Cargando…
Metal-organic frameworks for advanced drug delivery
Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular f...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424373/ https://www.ncbi.nlm.nih.gov/pubmed/34522591 http://dx.doi.org/10.1016/j.apsb.2021.03.019 |
_version_ | 1783749661755965440 |
---|---|
author | He, Siyu Wu, Li Li, Xue Sun, Hongyu Xiong, Ting Liu, Jie Huang, Chengxi Xu, Huipeng Sun, Huimin Chen, Weidong Gref, Ruxandra Zhang, Jiwen |
author_facet | He, Siyu Wu, Li Li, Xue Sun, Hongyu Xiong, Ting Liu, Jie Huang, Chengxi Xu, Huipeng Sun, Huimin Chen, Weidong Gref, Ruxandra Zhang, Jiwen |
author_sort | He, Siyu |
collection | PubMed |
description | Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular for drug delivery. There is a growing interest over the last decades in the design of engineered MOFs with controlled sizes for a variety of biomedical applications. This article presents an overall review and perspectives of MOFs-based drug delivery systems (DDSs), starting with the MOFs classification adapted for DDSs based on the types of constituting metals and ligands. Then, the synthesis and characterization of MOFs for DDSs are developed, followed by the drug loading strategies, applications, biopharmaceutics and quality control. Importantly, a variety of representative applications of MOFs are detailed from a point of view of applications in pharmaceutics, diseases therapy and advanced DDSs. In particular, the biopharmaceutics and quality control of MOFs-based DDSs are summarized with critical issues to be addressed. Finally, challenges in MOFs development for DDSs are discussed, such as biostability, biosafety, biopharmaceutics and nomenclature. |
format | Online Article Text |
id | pubmed-8424373 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-84243732021-09-13 Metal-organic frameworks for advanced drug delivery He, Siyu Wu, Li Li, Xue Sun, Hongyu Xiong, Ting Liu, Jie Huang, Chengxi Xu, Huipeng Sun, Huimin Chen, Weidong Gref, Ruxandra Zhang, Jiwen Acta Pharm Sin B Review Metal-organic frameworks (MOFs), comprised of organic ligands and metal ions/metal clusters via coordinative bonds are highly porous, crystalline materials. Their tunable porosity, chemical composition, size and shape, and easy surface functionalization make this large family more and more popular for drug delivery. There is a growing interest over the last decades in the design of engineered MOFs with controlled sizes for a variety of biomedical applications. This article presents an overall review and perspectives of MOFs-based drug delivery systems (DDSs), starting with the MOFs classification adapted for DDSs based on the types of constituting metals and ligands. Then, the synthesis and characterization of MOFs for DDSs are developed, followed by the drug loading strategies, applications, biopharmaceutics and quality control. Importantly, a variety of representative applications of MOFs are detailed from a point of view of applications in pharmaceutics, diseases therapy and advanced DDSs. In particular, the biopharmaceutics and quality control of MOFs-based DDSs are summarized with critical issues to be addressed. Finally, challenges in MOFs development for DDSs are discussed, such as biostability, biosafety, biopharmaceutics and nomenclature. Elsevier 2021-08 2021-03-13 /pmc/articles/PMC8424373/ /pubmed/34522591 http://dx.doi.org/10.1016/j.apsb.2021.03.019 Text en © 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Review He, Siyu Wu, Li Li, Xue Sun, Hongyu Xiong, Ting Liu, Jie Huang, Chengxi Xu, Huipeng Sun, Huimin Chen, Weidong Gref, Ruxandra Zhang, Jiwen Metal-organic frameworks for advanced drug delivery |
title | Metal-organic frameworks for advanced drug delivery |
title_full | Metal-organic frameworks for advanced drug delivery |
title_fullStr | Metal-organic frameworks for advanced drug delivery |
title_full_unstemmed | Metal-organic frameworks for advanced drug delivery |
title_short | Metal-organic frameworks for advanced drug delivery |
title_sort | metal-organic frameworks for advanced drug delivery |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424373/ https://www.ncbi.nlm.nih.gov/pubmed/34522591 http://dx.doi.org/10.1016/j.apsb.2021.03.019 |
work_keys_str_mv | AT hesiyu metalorganicframeworksforadvanceddrugdelivery AT wuli metalorganicframeworksforadvanceddrugdelivery AT lixue metalorganicframeworksforadvanceddrugdelivery AT sunhongyu metalorganicframeworksforadvanceddrugdelivery AT xiongting metalorganicframeworksforadvanceddrugdelivery AT liujie metalorganicframeworksforadvanceddrugdelivery AT huangchengxi metalorganicframeworksforadvanceddrugdelivery AT xuhuipeng metalorganicframeworksforadvanceddrugdelivery AT sunhuimin metalorganicframeworksforadvanceddrugdelivery AT chenweidong metalorganicframeworksforadvanceddrugdelivery AT grefruxandra metalorganicframeworksforadvanceddrugdelivery AT zhangjiwen metalorganicframeworksforadvanceddrugdelivery |